Vertebral compression fracture after stereotactic ablative radiotherapy in patients with oligometastatic bone lesions from hepatocellular carcinoma

Santini, 2014, Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey, PLoS One, 9, e105268, 10.1371/journal.pone.0105268 Kudo, 2018, Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial, Lancet, 391, 1163, 10.1016/S0140-6736(18)30207-1 Marrero, 2018, Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases, Hepatology, 68, 723, 10.1002/hep.29913 Chow, 2007, Palliative radiotherapy trials for bone metastases: a systematic review, J Clin Oncol, 25, 1423, 10.1200/JCO.2006.09.5281 Palma, 2020, Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET Phase II randomized trial, J Clin Oncol, 38, 2830, 10.1200/JCO.20.00818 Kim, 2021, Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma, J Cancer Res Clin Oncol, 147, 2693, 10.1007/s00432-021-03553-2 Jawad, 2016, Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation, J Neurosurg Spine, 24, 928, 10.3171/2015.10.SPINE141261 Lam, 2015, Adverse outcomes after palliative radiation therapy for uncomplicated spine metastases: role of spinal instability and single-fraction radiation therapy, Int J Radiat Oncol Biol Phys, 93, 373, 10.1016/j.ijrobp.2015.06.006 Lee, 2018, Evaluation of predictive factors of vertebral compression fracture after conventional palliative radiotherapy for spinal metastasis from colorectal cancer, J Neurosurg Spine, 28, 333, 10.3171/2017.6.SPINE17282 Common Terminology Criteria forAdverse Events (CTCAE) Version 4.0. National Institutes of Health: National Cancer Institute. Cox, 2012, International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, 83, e597, 10.1016/j.ijrobp.2012.03.009 Timmerman, 2008, An overview of hypofractionation and introduction to this issue of seminars in radiation oncology, Semin Radiat Oncol, 18, 215, 10.1016/j.semradonc.2008.04.001 Benedict, 2010, Stereotactic body radiation therapy: the report of AAPM Task Group 101, Med Phys, 37, 4078, 10.1118/1.3438081 Rose, 2009, Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases, J Clin Oncol, 27, 5075, 10.1200/JCO.2008.19.3508 Gray, 1988, A class of K-sample tests for comparing the cumulative incidence of a competing risk, Ann Stat, 16, 1141, 10.1214/aos/1176350951 Sahgal, 2013, Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score, J Clin Oncol, 31, 3426, 10.1200/JCO.2013.50.1411 Sahgal, 2013, Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases, Lancet Oncol, 14, e310, 10.1016/S1470-2045(13)70101-3 He, 2009, Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy, Cancer, 115, 2710, 10.1002/cncr.24300 Boehling, 2012, Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases, J Neurosurg Spine, 16, 379, 10.3171/2011.11.SPINE116 Santini, 2012, Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study, Ann Oncol, 23, 2072, 10.1093/annonc/mdr572 Seo, 2011, Evaluation of bone metastasis from hepatocellular carcinoma using (18)F-FDG PET/CT and (99m)Tc-HDP bone scintigraphy: characteristics of soft tissue formation, Nucl Med Mol Imaging, 45, 203, 10.1007/s13139-011-0099-3 Kim, 2007, Bone metastasis from primary hepatocellular carcinoma: characteristics of soft tissue formation, Cancer Res Treat, 39, 104, 10.4143/crt.2007.39.3.104